Paul Emery

Top papers

• 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

  Daniel Aletaha, Tuhina Neogi, Alan J. Silman, et al.·2010·Arthritis & Rheumatism
  ↗ 9,472OA
• Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis

  Peter E. Lipsky, Désirée van der Heijde, E. William St. Clair, et al.·2000·New England Journal of Medicine
  ↗ 3,017OA
• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

  Josef S Smolen, Robert Landewé, J. W. J. Bijlsma, et al.·2020·Annals of the Rheumatic Diseases
  ↗ 2,731OA
• Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis

  Jonathan Edwards, L Szczepański, Jacek Szechiński, et al.·2004·New England Journal of Medicine
  ↗ 2,583OA
• Rheumatoid arthritis

  Josef S Smolen, Daniel Aletaha, Anne Barton, et al.·2018·Nature Reviews Disease Primers
  ↗ 2,408OA
• Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

  Ravinder N. Maini, E. William St. Clair, Ferdinand C. Breedveld, et al.·1999·The Lancet
  ↗ 2,352
• Treating rheumatoid arthritis to target: recommendations of an international task force

  Josef S Smolen, D. Aletaha, J. W. J. Bijlsma, et al.·2010·Annals of the Rheumatic Diseases
  ↗ 2,083OA
• EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

  Josef S Smolen, Robert Landewé, Ferdinand C. Breedveld, et al.·2013·Annals of the Rheumatic Diseases
  ↗ 1,760OA
• Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial evaluating primary efficacy and safety at twenty‐four weeks

  Stanley Cohen, Paul Emery, Maria Greenwald, et al.·2006·Arthritis & Rheumatism
  ↗ 1,633
• \nEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.

  Josef S Smolen, Robert Landewé, Ferdinand C. Breedveld, et al.·2010·Radboud Repository (Radboud University)
  ↗ 1,624OA
• Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

  Josef S Smolen, Ferdinand C. Breedveld, Gerd R Burmester, et al.·2015·Annals of the Rheumatic Diseases
  ↗ 1,445OA
• Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci

  Eli A. Stahl, Soumya Raychaudhuri, Elaine F. Remmers, et al.·2010·Nature Genetics
  ↗ 1,276